Attana's presentation from Redeye Theme: Diagnostics is now available on Redeye's website

On Tuesday, September 27 at 09.30, Attana participated in Redeye’s event, Theme: Diagnostics, where Attana’s CEO, Teodor Aastrup, gave a 12-minute presentation followed by an 8-minute Q&A.

The presentation focused on how Attana’s technology can be used within companion diagnostics and to measure the neutralization capacity of e.g., antibodies.

The video can be found by following this link:

Attana – Redeye Theme: Diagnostics

For more information, please contact:

Teodor Aastrup, CEO
teodor.aastrup@attana.com
+46 (0)8 674 57 00

The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share price but is of general interest for the shareholders and hence should be communicated.

About Attana

Attana was founded in 2002 with the vision of in vitro characterization of molecular interactions mimicking in vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays and the Attana Virus Analytics (AVA) platform, a proprietary in vitro diagnostics (IVD) tool. Attana products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about our latest services and products, please visit www.attana.com or contact sales@attana.com

Tags: